Wall Street Analysts See Prenetics Global Limited (PRE) as a Buy: Should You Invest?Zacks Investment Research • 06/09/23
Should You Invest in Prenetics Global Limited (PRE) Based on Bullish Wall Street Views?Zacks Investment Research • 05/24/23
Prenetics Global Limited (PRE) Flat As Market Gains: What You Should KnowZacks Investment Research • 05/17/23
Wall Street Analysts Look Bullish on Prenetics Global Limited (PRE): Should You Buy?Zacks Investment Research • 05/08/23
Prenetics Global Limited (PRE) Loses -24.21% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 03/23/23
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision OncologyGlobeNewsWire • 03/02/23
Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceGlobeNewsWire • 02/02/23
Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEAGlobeNewsWire • 01/19/23
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid TumorsGlobeNewsWire • 01/10/23
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision OncologyGlobeNewsWire • 12/16/22
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap IndexGlobeNewsWire • 11/30/22
Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA GuidanceGlobeNewsWire • 11/10/22
Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA OutlookGlobeNewsWire • 09/09/22
Prenetics Announces First Quarter 2022 Financial Results After a Successful Listing on the Nasdaq under the Ticker “PRE.”GlobeNewsWire • 06/06/22